http://emedicine.medscape.com/article/336281-overview
Quote from the bottom of the above link
De Leon et al concluded that the combined use of conventional imaging, such as MRI or fluorodeoxyglucose PET (FDG-PET) scanning, with selected CSF biomarkers can incrementally contribute to the early and specific diagnosis of Alzheimer disease. Moreover, selected combinations of imaging and CSF biomarker measures are of importance in monitoring the course of Alzheimer disease and, therefore, are relevant to evaluating clinical trials
http://emedicine.medscape.com/article/336281-overviewQuote from...
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $3.446K | 1.148M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 60 | 109813434 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 1195573 | 1 |
View Market Depth
| Last trade - 15.42pm 28/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |